CD4/CD8 double-negative T-cell lymphoma successfully treated with a combination of bexarotene and total skin electron beam therapy
Ayano Tanigawa
Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
Search for more papers by this authorCorresponding Author
Takeshi Fukumoto
Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
Correspondence
Takeshi Fukumoto, Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan.
Email: [email protected]
Search for more papers by this authorShinya Imamura
Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
Search for more papers by this authorKorefumi Nakamura
Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
Search for more papers by this authorTomonori Tanaka
Division of Pathology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
Search for more papers by this authorTomoo Itoh
Division of Pathology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
Search for more papers by this authorEiji Nakano
Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
Search for more papers by this authorChikako Nishigori
Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
Search for more papers by this authorAkiharu Kubo
Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
Search for more papers by this authorAyano Tanigawa
Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
Search for more papers by this authorCorresponding Author
Takeshi Fukumoto
Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
Correspondence
Takeshi Fukumoto, Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan.
Email: [email protected]
Search for more papers by this authorShinya Imamura
Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
Search for more papers by this authorKorefumi Nakamura
Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
Search for more papers by this authorTomonori Tanaka
Division of Pathology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
Search for more papers by this authorTomoo Itoh
Division of Pathology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
Search for more papers by this authorEiji Nakano
Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
Search for more papers by this authorChikako Nishigori
Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
Search for more papers by this authorAkiharu Kubo
Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
Search for more papers by this author
Supporting Information
| Filename | Description |
|---|---|
| jde16739-sup-0001-FigureS2.jpgimage/jpp, 612.3 KB |
Figure S2 |
| jde16739-sup-0002-FigureS1.jpgimage/jpp, 1.6 MB |
Figure S1 |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
REFERENCES
- 1Hodak E, David M, Maron L, Aviram A, Kaganovsky E, Feinmesser M. CD4/CD8 double-negative epidermotropic cutaneous T-cell lymphoma: an immunohistochemical variant of mycosis fungoides. J Am Acad Dermatol. 2006; 55: 276–84.
- 2Miyauchi T, Abe R, Morita Y, Adachi M, Shiba K, Hamade Y, et al. CD4/CD8 double-negative T-cell lymphoma: a variant of primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma? Acta Derm Venereol. 2015; 95: 1024–5.
- 3Lowe MN, Plosker GL. Bexarotene. Am J Clin Dermatol. 2000; 1: 245–50.
- 4Duvic M, Hymes K, Heald P, Breneman D, Martin AG, Myskowski P, et al. Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial results. J Clin Oncol. 2001; 19: 2456–71.
- 5Elsayad K, Rolf D, Sunderkötter C, Weishaupt C, Müller EC, Nawar T, et al. Low-dose total skin electron beam therapy plus oral bexarotene maintenance therapy for cutaneous T-cell lymphoma. J Dtsch Dermatol Ges. 2022; 20: 279–85.
